Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Haystack Oncology enables precision oncology to optimize treatment strategies.
ALENTIS Therapeutics is a Swiss-French biotech company developing novel therapeutics in advanced liver disease and cancer.
Orasis Pharmaceuticals is an ophthalmic pharmaceutical company that develops eye drops for the treatment of presbyopia.
Bridging the gap between patients and researchers
Immunai is a biotech company that provides mapping and reprogramming immunology, machine learning, and software engineering.
AtaiBeckley develops innovative mental health treatments that address significant unmet medical needs.
Sunbird Bio is a diagnostics platform developer that aims to give molecular diagnostics with faster outcomes.
Imperative Care is singularly dedicated to finding meaningful answers to unsolved problems in stroke.
Avava is a Pioneer precision skin therapy to improve the quality of life for patients around the world.
Somethings is a platform for wellness tailored to young people that links youngsters with qualified mentors.
Lila Sciences creates a scientific superintelligence platform and autonomous labs for life sciences, chemistry, and materials science.
PrognomiQ is a biotechnology firm that develops test products to detect early disease detection through the power of multi-omics data.
Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.
Medra AI develops an autonomous scientific experimentation platform that combines robotics with artificial intelligence.
Hyperfine makes MRI accessible to every patient regardless of income or resources.
Freenome is a biotechnology company developing blood tests for early cancer detection to improve access to routine screening.
Imbria Pharmaceuticals is a clinical stage biotechnology company developing novel therapies for cardiometabolic diseases.
Beacon Biosignals is a neurotechnology company that brings precision neuroscience into clinical trials and treatments.
Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.
Cartography is an oncology company that develops cancer immunotherapies that target novel and highly specific tumor antigens.
Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers.
Ensomaa is a genomic medicine company that develops on one-time in vivo treatments for immuno-oncology and other therapeutic applications.
Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.
Enveda Biosciences is a biotechnology company that develops novel medications derived from plants.
Catalio Capital Management has invested in 132 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Catalio Capital Management's top investment sectors include Biotechnology, Health Care, Medical, Life Science, Therapeutics. The firm invests across 26 different industry categories.
Among tracked funding rounds, Parabilis Medicines received $305.0M in a Series F round. Catalio Capital Management's total known invested capital is $12.7B.
Catalio Capital Management's average investment size is $93.1M across its portfolio of 132 companies.
Recent Catalio Capital Management portfolio additions include Haystack Oncology, Alentis Therapeutics, Orasis Pharmaceuticals, Sanguine, Immunai. These companies were founded in 2020 or later.